GLP-1 receptor agonists have transformed the landscape of medical weight loss. Originally developed for type 2 diabetes, these medications were found to produce significant weight reduction as a secondary effect — and the clinical data has been remarkable.
What Is GLP-1?
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces in the gut after eating. It signals to your brain that you're full, slows gastric emptying so food stays in your stomach longer, and helps regulate blood sugar by stimulating insulin release.
In people with obesity or excess weight, this signaling system often doesn't work as effectively as it should. GLP-1 receptor agonist medications — like semaglutide — mimic and amplify this natural hormone, restoring the satiety signals your body has been missing.
The Clinical Evidence
Large-scale clinical trials have demonstrated that GLP-1 medications can help patients achieve 15-20% body weight reduction when combined with lifestyle modifications. This is significantly more than diet and exercise alone, which typically produces 3-5% weight loss in clinical settings.
Importantly, the weight loss is sustained. Patients who continue treatment maintain their results, and the metabolic benefits — improved cholesterol, blood pressure, and blood sugar — compound over time.
How Treatment Works at VevaMD
When you start a GLP-1 program through VevaMD, a licensed provider reviews your health history, current medications, and weight loss goals. If you're a candidate, they prescribe a compounded semaglutide formulation tailored to your needs.
Treatment typically starts at a lower dose and gradually increases over several weeks. This titration period helps minimize side effects — primarily mild nausea — while your body adjusts. Your provider monitors your progress and adjusts dosing based on your response.
What to Expect
- Week 1-4: Reduced appetite and early weight loss (3-5 lbs typical)
- Month 2-3: More significant weight loss as dose is optimized
- Month 3-6: Steady weight loss of 1-2 lbs per week on average
- Month 6+: Continued loss and maintenance, ongoing provider optimization
Is It Right for You?
GLP-1 medications are typically prescribed for adults with a BMI of 30+ (obese) or 27+ (overweight) with at least one weight-related health condition. Your VevaMD provider will evaluate your eligibility during the initial consultation — the entire process is online, takes about 5 minutes to start, and requires no office visits.
VevaMD is a technology platform, not a medical provider. All prescriptions are written by independent licensed clinicians. Individual results vary.